U.S. Markets closed
  • S&P 500

    4,185.47
    +15.05 (+0.36%)
     
  • Dow 30

    34,200.67
    +164.68 (+0.48%)
     
  • Nasdaq

    14,052.34
    +13.58 (+0.10%)
     
  • Russell 2000

    2,262.67
    +5.60 (+0.25%)
     
  • Crude Oil

    63.07
    -0.39 (-0.61%)
     
  • Gold

    1,777.30
    +10.50 (+0.59%)
     
  • Silver

    26.04
    +0.08 (+0.29%)
     
  • EUR/USD

    1.1980
    +0.0004 (+0.0359%)
     
  • 10-Yr Bond

    1.5730
    +0.0430 (+2.81%)
     
  • Vix

    16.25
    -0.32 (-1.93%)
     
  • GBP/USD

    1.3840
    +0.0056 (+0.4069%)
     
  • USD/JPY

    108.7830
    +0.0670 (+0.0616%)
     
  • BTC-USD

    60,907.63
    -507.75 (-0.83%)
     
  • CMC Crypto 200

    1,398.97
    +7.26 (+0.52%)
     
  • FTSE 100

    7,019.53
    +36.03 (+0.52%)
     
  • Nikkei 225

    29,683.37
    +40.68 (+0.14%)
     

Cramer Weighs In On Lumber Liquidators, HCA Healthcare And More

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Craig Jones
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

On CNBC's "Mad Money Lightning Round," Jim Cramer said that he is not a buyer of BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX). He would rather own Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Eli Lilly And Co (NYSE: LLY).

Lumber Liquidators Holdings Inc (NYSE: LL) is not a great company, said Cramer. He added that it is now in the sweet spot of business, so you can buy it and it could go higher.

Instead of Jumia Technologies AG - ADR (NYSE: JMIA), Cramer would buy Amazon.com, Inc. (NASDAQ: AMZN).

Cramer prefers Alibaba Group Holding Ltd - ADR (NYSE: BABA) over Nio Inc - ADR (NYSE: NIO).

Instead of GTT Communications Inc (NYSE: GTT), Cramer wants to buy Skyworks Solutions Inc (NASDAQ: SWKS), Marvell Technology Group Ltd. (NASDAQ: MRVL), Qorvo Inc (NASDAQ: QRVO) and QUALCOMM, Inc. (NASDAQ: QCOM).

HCA Healthcare Inc (NYSE: HCA) is undervalued because everybody knows that COVID-19 has hurt it, said Cramer.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.